Corcept Therapeutics Inc (CORT)
ROA
Obliczenia
|
2022/Q4 (31 gru 2022) |
2022/Q3 (30 wrz 2022) |
2022/Q2 (30 cze 2022) |
2022/Q1 (31 mar 2022) |
2021/Q4 (31 gru 2021) |
2021/Q3 (30 wrz 2021) |
2021/Q2 (30 cze 2021) |
2021/Q1 (31 mar 2021) |
||
|---|---|---|---|---|---|---|---|---|---|
| Zysk netto (ttm) | w tys. USD | 101 418 | 116 870 | 112 733 | 111 844 | 112 512 | 106 453 | 97 607 | 99 411 |
| Aktywa razem | w tys. USD | 583 430 | 533 255 | 496 364 | 468 123 | 423 756 | 585 399 | 568 480 | 552 398 |
| ROA | 17,38% | 21,92% | 22,71% | 23,89% | 26,55% | 18,18% | 17,17% | 18,00% |
2022/Q4 obliczenia
ROA = Zysk netto (ttm) ÷ Aktywa razem
= $101 418K ÷ $583 430K
= 17,38%
Analiza porównawcza
2022/Q4
Nazwa spółki
Symbol
ROA
Corcept Therapeutics Inc
CORT
17,38%
Amphastar Pharmaceuticals Inc
AMPH
12,32%
Arrowhead Pharmaceuticals Inc.
ARWR
-17,33%
Harmony Biosciences Holdings Inc
HRMY
26,93%
Ironwood Pharmaceuticals Inc
IRWD
15,91%
Myriad Genetics, Inc.
MYGN
-9,34%
Pacira BioSciences Inc
PCRX
0,95%
Prestige Consumer Healthcare Inc
PBH
5,61%
Supernus Pharmaceuticals Inc
SUPN
2,22%
Xencor Inc
XNCR
-6,52%